Efficient T-cell engineering is crucial for the success of CAR T-cell therapy research, but it requires multiple labor-intensive steps, including T-cell isolation, activation, and transduction.

Chinese scientists have developed a new method that enhances tumor immunotherapy, including the widely popular Bispecific T-cell engager, or BiTE therapy, by precisely labeling tumor cells and ...

Late Breaking Abstract to Present Additional Data from Aclaris’ Phase 2a Trial of ATI-2138 in Atopic Dermatitis-WAYNE, Pa., Sept. 09, 2025 ...

HCW Biologics conducted investigative study to show safe dose levels of its lead drug candidate in non-human primates that were well tolerated at ...

Scientists have uncovered a sweet twist in the body’s fight against cancer. Glucose, best known as the fuel that powers our ...

The firm, founded on research from the University of Pennsylvania, says it can manufacture the cells in just three days using cell-derived nanoparticles.